De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Maravai LifeSciences Holdings Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Maravai LifeSciences Holdings heeft een totaal eigen vermogen van $776.4M en een totale schuld van $522.5M, wat de schuld-eigenvermogensverhouding op 67.3% brengt. De totale activa en totale passiva bedragen respectievelijk $1.4B en $671.2M.
Belangrijke informatie
67.3%
Verhouding schuld/eigen vermogen
US$522.52m
Schuld
| Rente dekkingsratio | n/a |
| Contant | US$579.75m |
| Aandelen | US$776.41m |
| Totaal verplichtingen | US$671.19m |
| Totaal activa | US$1.45b |
Recente financiële gezondheidsupdates
Recent updates
Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) 29% Jump Shows Its Popularity With Investors
Jul 18
Does Maravai LifeSciences Holdings (NASDAQ:MRVI) Have A Healthy Balance Sheet?
Jul 15Maravai: Embedded Expectations Remain Too High Considering Economic Calculus
Jul 12RGA Investment Advisors - Maravai: Two Elite Assets With Other-Worldly Margins Wrapped In One
Jun 12Revenues Tell The Story For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) As Its Stock Soars 25%
May 14An Intrinsic Calculation For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Suggests It's 23% Undervalued
Apr 07Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stocks Shoot Up 28% But Its P/S Still Looks Reasonable
Feb 28Revenues Working Against Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Share Price
Dec 19Need To Know: Analysts Just Made A Substantial Cut To Their Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Estimates
Aug 14Are Investors Undervaluing Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) By 27%?
Feb 28Is Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 01Maravai Lifesciences temporarily reinstates Carl Hull as CEO
Oct 19Maravai LifeSciences appoints former Danaher executive as CEO
Oct 03Maravai LifeSciences Holdings GAAP EPS of $0.53 beats by $0.15, revenue of $242.73M beats by $9.51M
Aug 04Estimating The Intrinsic Value Of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)
Jun 27Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Intrinsic Value Is Potentially 25% Below Its Share Price
Mar 29Maravai Faces Skeptical Investors As Pandemic Enters New Period
Jan 27Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Share Price Could Signal Some Risk
Dec 02Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $685.4M ) MRVI } overtreffen de korte termijn passiva ( $68.6M ).
Langlopende schulden: De kortetermijnactiva MRVI ( $685.4M ) overtreffen de langetermijnschulden ( $602.6M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: MRVI heeft meer geld in kas dan de totale schuld.
Schuld verminderen: De schuld/eigen vermogen-ratio van MRVI is de afgelopen 5 jaar gedaald van 230.8% naar 67.3%.
Schuldendekking: De schuld van MRVI wordt niet goed gedekt door de operationele kasstroom ( 5.9% ).
Rentedekking: Er zijn onvoldoende gegevens om te bepalen of de rentebetalingen van MRVI op haar schulden goed worden gedekt door EBIT.